Showing 1 - 5 results of 5 for search 'Joong‐Won Park', query time: 0.06s Refine Results
  1. 1
    Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment

    Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment by Bo Hyun Kim, Joong-Won Park

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment

    A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment by Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria

    Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case... by Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

    Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab by Tae Hyun Kim, Bo Hyun Kim, Yu Ri Cho, Young-Hwan Koh, Joong-Won Park

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors

    Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors by Hark Kyun Kim, Jeong Won Kang, Young‐Whan Park, Jung Young Kim, Minchae Kim, Soo Jin Kim, Se‐mi Kim, Keun Ho Ryu, Seonghae Yoon, Yun Kim, Joo‐Youn Cho, Keun Seok Lee, Tak Yun, Kiwon Kim, Mi Hyang Kwak, Tae‐Sung Kim, Jinsoo Chung, Joong‐Won Park

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: